Reuters logo
BRIEF-Piramal Enterprises completes drug portfolio acquisition from Mallinckrodt LLC
March 20, 2017 / 4:27 AM / 8 months ago

BRIEF-Piramal Enterprises completes drug portfolio acquisition from Mallinckrodt LLC

March 20 (Reuters) - Piramal Enterprises Ltd:

* Piramal Enterprises completes acquisition of a portfolio of drugs for spasticity and pain management from Mallinckrodt LLC Source text: (bit.ly/2n55MD8) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below